Notably, astrocyte activation has also been noted in ALS patients, where it may significantly impact the progression of ALS by mediating the SQSTM1/p62-Nrf2 antioxidative stress pathway [155]. The gene discussed is NFE2L2; the disease is amyotrophic lateral sclerosis.